REFERENCES
1. Tiniakos DG, Kandilis A, Geller SA. Tityus: a forgotten myth of liver regeneration. J Hepatol. 2010;53:357-61.
2. Kattner AA. Greek gods and the double-edged sword of liver regeneration. Biomed J. 2021;44:515-20.
3. Michalopoulos GK, Bhushan B. Liver regeneration: biological and pathological mechanisms and implications. Nat Rev Gastroenterol Hepatol. 2021;18:40-55.
5. Colle I, Verhelst X, Vanlander A, et al. Pathophysiology and management of post resection liver failure. Acta Chir Belg. 2013;113:155-61.
6. Engelmann C. Peripheral fat mobilization and mitochondrial fat metabolism: Fueling the energy demands of liver regeneration. J Hepatol. 2025;82:942-4.
7. Smith RL, Soeters MR, Wüst RCI, Houtkooper RH. Metabolic flexibility as an adaptation to energy resources and requirements in health and disease. Endocr Rev. 2018;39:489-517.
8. Wang X, Menezes CJ, Jia Y, et al. Metabolic inflexibility promotes mitochondrial health during liver regeneration. Science. 2024;384:eadj4301.
9. Lund A, Thomsen MT, Kirkegård J, et al. Role of steatosis in preventing post-hepatectomy liver failure after major resection: findings from an animal study. J Clin Exp Hepatol. 2025;15:102453.
10. Peltec A, Hotineanu A, Popescu I, Braşoveanu V. The impact of liver steatosis on the postoperative evolution after right lobe living-donor hepatectomy. Med Pharm Rep. 2021;94 Suppl:S43-50.
11. Gilgenkrantz H, Collin de l’Hortet A. Understanding liver regeneration: from mechanisms to regenerative medicine. Am J Pathol. 2018;188:1316-27.
12. Hora S, Wuestefeld T. Liver injury and regeneration: current understanding, new approaches, and future perspectives. Cells. 2023;12:2129.
13. Boyce S, Harrison D. A detailed methodology of partial hepatectomy in the mouse. Lab Anim. 2008;37:529-32.
14. Zafarnia S, Mrugalla A, Rix A, et al. Non-invasive imaging and modeling of liver regeneration after partial hepatectomy. Front Physiol. 2019;10:904.
15. Xiaoguang Chen. A comprehensive review on liver regeneration termination: a non-neglectable phase. Cytol. Genet. 2024;58:343-61.
17. Zhao Y, Ye W, Wang YD, Chen WD. HGF/c-met: a key promoter in liver regeneration. Front Pharmacol. 2022;13:808855.
18. Théret N, Feret J, Hodgkinson A, Boutillier P, Vignet P, Radulescu O. Integrative models for TGF-β signaling and extracellular matrix. In: Ricard-Blum S, Editors. Extracellular matrix omics. Cham: Springer International Publishing; 2020. pp. 209-25.
19. Sljukic A, Green Jenkinson J, Niksic A, Prior N, Huch M. Advances in liver and pancreas organoids: how far we have come and where we go next. Nat Rev Gastroenterol Hepatol. 2026;23:44-64.
20. Malato Y, Naqvi S, Schürmann N, et al. Fate tracing of mature hepatocytes in mouse liver homeostasis and regeneration. J Clin Invest. 2011;121:4850-60.
21. Wei Y, Wang YG, Jia Y, et al. Liver homeostasis is maintained by midlobular zone 2 hepatocytes. Science. 2021;371.
22. He L, Pu W, Liu X, et al. Proliferation tracing reveals regional hepatocyte generation in liver homeostasis and repair. Science. 2021;371:eabc4346.
23. Duan L, Chang Y, Dai J, et al. Lipid metabolism orchestrates liver regeneration: an integrated metabolic network. J Transl Med. 2025;23:1115.
24. Yang Q, Nagano T, Shah Y, Cheung C, Ito S, Gonzalez FJ. The PPAR alpha-humanized mouse: a model to investigate species differences in liver toxicity mediated by PPAR alpha. Toxicol Sci. 2008;101:132-9.
25. Shizu R, Makida N, Sobe K, et al. Interaction with YAP underlies the species differences between humans and rodents in CAR-dependent hepatocyte proliferation. Toxicol Sci. 2024;198:101-12.
26. Koch PS, Sandorski K, Heil J, et al. Imbalanced activation of Wnt-/β-catenin-signaling in liver endothelium alters normal sinusoidal differentiation. Front Physiol. 2021;12:722394.
27. Visekruna A, Luu M. The role of short-chain fatty acids and bile acids in intestinal and liver function, inflammation, and carcinogenesis. Front Cell Dev Biol. 2021;9:703218.
28. Bhalla S, Mcquillen B, Cay E, Reau N. Preoperative risk evaluation and optimization for patients with liver disease. Gastroenterol Rep (Oxf). 2024;12:goae071.
29. Peloso A, Tihy M, Moeckli B, Rubbia-Brandt L, Toso C. Clearing steatosis prior to liver surgery for colorectal metastasis: a narrative review and case illustration. Nutrients. 2022;14:5340.
30. Ahmed EA, El-Badry AM, Mocchegiani F, et al. Impact of graft steatosis on postoperative complications after liver transplantation. Surg J (N Y). 2018;4:e188-96.
31. de Meijer VE, Kalish BT, Puder M, Ijzermans JN. Systematic review and meta-analysis of steatosis as a risk factor in major hepatic resection. Br J Surg. 2010;97:1331-9.
32. Islam SMT, Palanisamy AP, Chedister GR, Schmidt MG, Lewin DNB, Chavin KD. Unsaturated or saturated dietary fat-mediated steatosis impairs hepatic regeneration following partial hepatectomy in mice. PLoS ONE. 2023;18:e0284428.
33. Fujita K, Nozaki Y, Wada K, et al. Effectiveness of antiplatelet drugs against experimental non-alcoholic fatty liver disease. Gut. 2008;57:1583-91.
34. Holländer S, von Heesen M, Gäbelein G, et al. Perioperative treatment with cilostazol reverses steatosis and improves liver regeneration after major hepatectomy in a steatotic rat model. Sci Rep. 2025;15:2753.
